CirculationLetter
06 May 2025
No abstract available
S. Braumann received nonfinancial support from AstraZeneca and travel grants from Lilly. S.M.-M. received travel grants from Bayer Vital AG outside the submitted work and unrelated to the contents of this article. B.H. received speaker fees from Bristol Myers Squibb, Boehringer Ingelheim, and Pfizer, none of which related to the content of this article. V.t.C. received consulting fees from Bayer AG outside the submitted work and unrelated to the contents of this article. E.M., K.N., and M.A. are employees of and might own shares in AstraZeneca. N.F. reports lecture and consulting fees from AstraZeneca, Bayer, Boehringer Ingelheim, Novartis, and Pfizer Inc, none of which related to the content of this article. M.B. reports personal fees from Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Cytokinetics, Edwards, Medtronic, Novartis, Servier, and Vifor during the conduct of the study. S.F. has received consultancy and lecture fees as well as support/travel grants for meetings from Abbott, Abiomed, Amarin, Amgen, AstraZeneca, Bayer, Berlin-Chemie, Biotronik, Boehringer, Bristol Myers Squibb, Boehringer, Daiichi Sankyo, Edwards, Lilly, Novartis, Novo Nordisk, Pfizer, Sanofi-Aventis, Siemens, Vifor, and Zoll. P.S.W. reports outside the submitted work grants from Bayer AG, nonfinancial grants from Philips Medical Systems, grants and consulting fees from Boehringer Ingelheim, grants and consulting fees from Novartis Pharma, grants and consulting fees from Sanofi-Aventis, grants, consulting, and lecturing fees from Bayer Health Care, grants and consulting fees from Daiichi Sankyo Europe, lecturing fees from Pfizer Pharma, lecturing fees from Bristol Myers Squibb, consulting fees from AstraZeneca, consulting fees and nonfinancial support from Diasorin, and nonfinancial support from IEM. S. Baldus received lecture and speaker fees from Abbot, Edwards, and AstraZeneca. The other authors report no conflicts.
More resources:
Share: